全球心血管设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球心血管器材市场需求预计将从2023年的501.8亿美元达到2032年近969.3亿美元的市场规模，2024-2032年研究期间复合年增长率为7.59%。

心血管设备旨在诊断、监测、治疗或管理影响心血管系统（包括心臟和血管）的疾病。这些设备涵盖了许多产品，例如植入式心律调节器、除颤器、支架、导管、心臟监视器和血管移植物等。

市场动态

由于人口老化、久坐的生活方式以及糖尿病、肥胖和高血压等危险因子发生率的上升，冠状动脉疾病、心臟衰竭和心律不整等心血管疾病的负担日益增加，导致对诊断和治疗的需求不断成长。这些设备，包括植入式心臟监视器、起搏器、除颤器、支架和导管，在诊断、治疗和管理各种心血管疾病方面发挥关键作用，推动了患者、医疗保健提供者和付款人的市场采用。此外，机器人辅助手术、微创手术和远端监测系统等医疗技术的进步扩大了心血管设备的功能和应用，为患者提供了更安全、更精准和微创的治疗选择，推动了市场创新和差异化。此外，人们对预防心臟病学、早期检测和个人化医疗的日益重视，刺激了对心电图 (ECG) 机、超音波心动图系统和心臟成像模式等心血管诊断设备的需求，从而推动了市场扩张。此外，不断增加的研发活动投资旨在开发具有更高安全性、有效性和可用性的下一代心血管设备、监管部门的批准以及新颖产品和技术的市场推出，预计将进一步推动市场成长和竞争力。

最后，COVID-19 大流行对医疗保健服务、远距医疗采用和患者护理途径的影响加速了远端监控、数位健康解决方案和家用心血管设备的采用，推动了市场对创新远端监控系统、穿戴式设备的需求。然而，医疗保健政策的变化、监管限制以及替代治疗方式的竞争可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心血管设备市场的各个细分市场进行了包容性评估。心血管器械产业的成长和趋势为本研究提供了整体方法。

市场区隔

心血管设备市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

• 诊断与监测设备（心电图、动态心电图监测仪、事件监测仪、植入式循环记录器、超音波心臟检查、宠物扫描、MRI、心臟 Ct、多普勒胎儿监视器、心臟诊断导管）
• 手术器械（心律调节器、支架、导管及配件、导线、插管、电外科手术、瓣膜、闭塞装置）

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心血管设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心血管设备市场的主要参与者包括 Abbott、GE HealthCare、Edwards Lifesciences Corporation、WL Gore & Associates, Inc.、Siemens Healthcare GmbH、BIOTRONIK SE & Co. KG、Canon Medical Systems Asia Pte.。有限公司、B. Braun SE、LivaNova PLC、Cardinal Health、Medtronic、波士顿科学公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：心血管设备 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球心血管设备市场分析：按产品

• 按产品概述
• 历史和预测数据
• 按产品分析
• 诊断与监测设备（心电图、动态心电图监测仪、事件监测仪、植入式循环记录器、超音波心臟检查、PET 扫描、MRI、心臟 CT、多普勒胎儿监视器、心臟诊断导管）
• 手术器械（心律调节器、支架、导管及配件、导线、插管、电外科手术、瓣膜、闭塞装置）

第 6 章：全球心血管设备市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 7 章：心血管器材公司的竞争格局

• 心血管器材市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 8 章：公司简介

• 公司股份分析
• 市场集中度
• Abbott
• 公司简介
• 公司收入
• 产品
• 最近的发展
• GE HealthCare
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Edwards Lifesciences Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• WL Gore & Associates Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Siemens Healthcare GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• BIOTRONIK SE & Co. KG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Canon Medical Systems Asia Pte. Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• B. Braun SE
• 公司简介
• 公司收入
• 产品
• 最近的发展
• LivaNova PLC
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cardinal Health
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Medtronic
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boston Scientific Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Cardiovascular Devices Market is presumed to reach the market size of nearly USD 96.93 Billion by 2032 from USD 50.18 Billion in 2023 with a CAGR of 7.59% under the study period 2024 - 2032.

Cardiovascular devices are designed to diagnose, monitor, treat, or manage conditions affecting the cardiovascular system, including the heart and blood vessels. These devices cover many products, such as implantable pacemakers, defibrillators, stents, catheters, cardiac monitors, and vascular grafts.

MARKET DYNAMICS

The increasing burden of cardiovascular diseases such as coronary artery disease, heart failure, and arrhythmias, driven by aging populations, sedentary lifestyles, and rising incidence of factors posing risks such as diabetes, obesity, and hypertension, has led to growing demand for diagnostic and therapeutic cardiovascular devices. These devices, including implantable cardiac monitors, pacemakers, defibrillators, stents, and catheters, play a critical role in diagnosing, treating, and managing various cardiovascular conditions, driving market adoption among patients, healthcare providers, and payers. Moreover, advancements in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and remote monitoring systems, have expanded the capabilities and applications of cardiovascular devices, enabling safer, more precise, and less invasive treatment options for patients, driving market innovation and differentiation. Moreover, the growing emphasis on preventive cardiology, early detection, and personalized medicine has fueled demand for cardiovascular diagnostic devices such as electrocardiography (ECG) machines, echocardiography systems, and cardiac imaging modalities, driving market expansion. Furthermore, the increasing investment in research and development activities aimed at developing next-generation cardiovascular devices with enhanced safety, efficacy, and usability, regulatory approvals, and market launches of novel products and technologies are expected to drive further market growth and competitiveness.

Lastly, the impact of the COVID-19 pandemic on healthcare delivery, telemedicine adoption, and patient care pathways has accelerated the adoption of remote monitoring, digital health solutions, and home-based cardiovascular devices, driving market demand for innovative remote monitoring systems, wearable devices, and mobile health apps that enable continuous monitoring and management of cardiovascular conditions in real-time, further fueling market expansion and diversification. However, changes in healthcare policies, regulatory constraints, and competition from alternative treatment modalities may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiovascular devices. The growth and trends of cardiovascular devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cardiovascular devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Diagnostic & Monitoring Devices (Ecg, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, Pet Scan, Mri, Cardiac Ct, Doppler Fetal Monitors, Cardiac Diagnostic Catheters)
• Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiovascular Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiovascular Devices market include Abbott, GE HealthCare, Edwards Lifesciences Corporation, W. L. Gore & Associates, Inc., Siemens Healthcare GmbH, BIOTRONIK SE & Co. KG, Canon Medical Systems Asia Pte. Ltd., B. Braun SE, LivaNova PLC, Cardinal Health, Medtronic, Boston Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CARDIOVASCULAR DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CARDIOVASCULAR DEVICES MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Diagnostic & Monitoring Devices (ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, PET Scan, MRI, Cardiac CT, Doppler Fetal Monitors, Cardiac Diagnostic Catheters) Historic and Forecast Sales by Regions
• 5.5 Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices) Historic and Forecast Sales by Regions

6 . GLOBAL CARDIOVASCULAR DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2. North America By Segment Sales Analysis
  • 6.3.3. North America By Country Sales Analysis
  • 6.3.4. United State Sales Analysis
  • 6.3.5. Canada Sales Analysis
  • 6.3.6. Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2. Europe by Segment Sales Analysis
  • 6.4.3. Europe by Country Sales Analysis
  • 6.4.4. United Kingdom Sales Analysis
  • 6.4.5. France Sales Analysis
  • 6.4.6. Germany Sales Analysis
  • 6.4.7. Italy Sales Analysis
  • 6.4.8. Russia Sales Analysis
  • 6.4.9. Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2. Asia Pacific by Segment Sales Analysis
  • 6.5.3. Asia Pacific by Country Sales Analysis
  • 6.5.4. China Sales Analysis
  • 6.5.5. India Sales Analysis
  • 6.5.6. Japan Sales Analysis
  • 6.5.7. South Korea Sales Analysis
  • 6.5.8. Australia Sales Analysis
  • 6.5.9. South East Asia Sales Analysis
  • 6.5.10. Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2. Latin America by Segment Sales Analysis
  • 6.6.3. Latin America by Country Sales Analysis
  • 6.6.4. Brazil Sales Analysis
  • 6.6.5. Argentina Sales Analysis
  • 6.6.6. Peru Sales Analysis
  • 6.6.7. Chile Sales Analysis
  • 6.6.8. Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2. Middle East & Africa by Segment Sales Analysis
  • 6.7.3. Middle East & Africa by Country Sales Analysis
  • 6.7.4. Saudi Arabia Sales Analysis
  • 6.7.5. UAE Sales Analysis
  • 6.7.6. Israel Sales Analysis
  • 6.7.7. South Africa Sales Analysis
  • 6.7.8. Rest Of Middle East And Africa Sales Analysis

7 . COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR DEVICES COMPANIES

• 7.1. Cardiovascular Devices Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8 . COMPANY PROFILES OF CARDIOVASCULAR DEVICES INDUSTRY

• 8.1. Company Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Abbott
  • 8.3.1. Company Overview
  • 8.3.2. Company Revenue
  • 8.3.3. Products
  • 8.3.4. Recent Developments
• 8.4. GE HealthCare
  • 8.4.1. Company Overview
  • 8.4.2. Company Revenue
  • 8.4.3. Products
  • 8.4.4. Recent Developments
• 8.5. Edwards Lifesciences Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Revenue
  • 8.5.3. Products
  • 8.5.4. Recent Developments
• 8.6. W. L. Gore & Associates Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Revenue
  • 8.6.3. Products
  • 8.6.4. Recent Developments
• 8.7. Siemens Healthcare GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Revenue
  • 8.7.3. Products
  • 8.7.4. Recent Developments
• 8.8. BIOTRONIK SE & Co. KG
  • 8.8.1. Company Overview
  • 8.8.2. Company Revenue
  • 8.8.3. Products
  • 8.8.4. Recent Developments
• 8.9. Canon Medical Systems Asia Pte. Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Company Revenue
  • 8.9.3. Products
  • 8.9.4. Recent Developments
• 8.10. B. Braun SE
  • 8.10.1. Company Overview
  • 8.10.2. Company Revenue
  • 8.10.3. Products
  • 8.10.4. Recent Developments
• 8.11. LivaNova PLC
  • 8.11.1. Company Overview
  • 8.11.2. Company Revenue
  • 8.11.3. Products
  • 8.11.4. Recent Developments
• 8.12. Cardinal Health
  • 8.12.1. Company Overview
  • 8.12.2. Company Revenue
  • 8.12.3. Products
  • 8.12.4. Recent Developments
• 8.13. Medtronic
  • 8.13.1. Company Overview
  • 8.13.2. Company Revenue
  • 8.13.3. Products
  • 8.13.4. Recent Developments
• 8.14. Boston Scientific Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Revenue
  • 8.14.3. Products
  • 8.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Diagnostic & Monitoring Devices (ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, PET Scan, MRI, Cardiac CT, Doppler Fetal Monitors, Cardiac Diagnostic Catheters) Market Sales by Geography (USD MN)
• Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices) Market Sales by Geography (USD MN)
• Global Cardiovascular Devices Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cardiovascular Devices Report
• Market Research Process
• Market Research Methodology
• Global Cardiovascular Devices Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Diagnostic & Monitoring Devices (ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Echocardiogram, PET Scan, MRI, Cardiac CT, Doppler Fetal Monitors, Cardiac Diagnostic Catheters) Market Sales by Geography (USD MN)
• Surgical Devices (Pacemakers, Stents, Catheters & Accessories, Guidewires, Cannulae, Electrosurgical Procedures, Valves, Occlusion Devices) Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.